GRANULES INDIA
Back to Balance Sheet
|
GRANULES INDIA Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹6,185 Cr | ₹5,484 Cr | ₹4,903 Cr | ₹4,512 Cr | ₹3,713 Cr |
What is the latest Total Liabilities ratio of GRANULES INDIA ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹6,185 Cr |
| Mar2024 | ₹5,484 Cr |
| Mar2023 | ₹4,903 Cr |
| Mar2022 | ₹4,512 Cr |
| Mar2021 | ₹3,713 Cr |
How is Total Liabilities of GRANULES INDIA Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹6,185 Cr | 12.78 | |
| Mar2024 | ₹5,484 Cr | 11.84 | |
| Mar2023 | ₹4,903 Cr | 8.68 | |
| Mar2022 | ₹4,512 Cr | 21.52 | |
| Mar2021 | ₹3,713 Cr | - | |
Compare Total Liabilities of peers of GRANULES INDIA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GRANULES INDIA | ₹14,020.8 Cr | 3% | 7.6% | 7.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹411,054.0 Cr | 0.9% | 6.2% | -1.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹167,075.0 Cr | 2% | 4.8% | 4.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹142,904.0 Cr | 3.6% | 6% | 36.9% | Stock Analytics | |
| CIPLA | ₹107,358.0 Cr | -0.1% | -3% | -8.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,813.0 Cr | 1% | 10.8% | 4.7% | Stock Analytics | |
GRANULES INDIA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GRANULES INDIA | 3% |
7.6% |
7.3% |
| SENSEX | -1.4% |
0.4% |
8.3% |
You may also like the below Video Courses